Formulation Licenses
Registered finished dosage forms (FDF), transferable tech packages and in-development in-licensing pipelines · delivered per target-market approval pathway
Formulation (FDF)
Glucosamine Sulfate Capsules
Capsules · 0.25g
- Therapy
- Others > Rheumatology
- Status
- Official FDF licensing catalog (UB591)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Prednisone Tablets
Tablets
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB590)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Methylprednisolone Tablets
Tablets
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB589)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Celecoxib Capsules
Capsules
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB588)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Olanzapine Orally Disintegrating Tablets
Tablets · 5mg; 10mg; 15mg; 20mg;
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB587)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Olanzapine Tablets
Tablets · 2.5mg; 5mg; 7.5mg; 10mg; 15mg; 20mg;
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB586)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Levetiracetam Extended-release Tablets
Tablets · 500mg; 750mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB585)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Donepezil Hydrochloride Orally Disintegrating Tablets
Tablets · 5mg; 10mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB584)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Aripiprazole Orally Disintegrating Tablets
Tablets · 10mg; 15mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB583)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Aripiprazole Tablets
Tablets · 2mg; 5mg; 10mg; 15mg; 20mg; 30mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB582)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Losartan Potassium Tablets
Tablets · 25mg; 50mg; 100mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB581)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Irbesartan and Hydrochlorothiazide Tablets
Tablets · 150mg/12.5mg; 300mg/12.5mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB580)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Mycophenolate Mofetil Tablets
Tablets · 500mg
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB579)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Mycophenolate Mofetil Capsules
Capsules · 250mg
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB578)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Fludarabine Phosphate Injection
Injection · 50mg/2mL
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB577)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Micafungin Sodium for Injection
for Injection · 50mg; 100mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB576)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Daptomycin for Injection
for Injection · 500mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB575)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Prednisolone Tablets
Tablets · 5mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB574)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Irbesartan Tablets
Tablets · 75mg; 150mg; 300mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB573)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Ticagrelor Tablets
Tablets · 90mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB572)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Daunorubicin Hydrochloride Injection
Injection · 20mg/4mL; 50mg/10mL
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB571)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Cladribine Injection
Injection · 10mg/10mL
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB570)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Dactinomycin for Injection
for Injection · 500mcg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB569)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Sodium Valproate Concentrated Solution for Injection
for Injection · 3ml:0.3g
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB559)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tirofiban Hydrochloride Injection
Injection · 15ml:3.75mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB558)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Neostigmine Methyl sulfate Injection
Injection · 1ml:0.5mg; 2ml:1mg; 4ml:2mg
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB557)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Pamidronate Disodium Injection
Injection · 10ml:30mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB556)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Potassium Chloride Injection
Injection · 10ml:1.5g
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB555)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Palonosetron Hydrochloride Injection
Injection · 5ml:0.25mg; 1.5ml:0.075mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB554)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Famotidine Injection
Injection · 2ml:20mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB553)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Compound Potassium Hydrogen Phosphate Injection
Injection · 5ml containing 1.2g potassium dihydrogen phosphate and 1.18g dipotassium hydrogen phosphate (as K₂HPO₄)
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB552)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Diprophylline Injection
Injection · 2ml:0.3g
- Therapy
- Respiratory
- Status
- Official FDF licensing catalog (UB551)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Bromhexine Hydrochloride Injection
Injection · 2ml:4mg
- Therapy
- Respiratory
- Status
- Official FDF licensing catalog (UB550)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Diprophylline Injection
Injection · 100ml:8g; 5ml:0.4g
- Therapy
- Respiratory
- Status
- Official FDF licensing catalog (UB549)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Bromhexine Hydrochloride Tablets
Tablets · 8mg
- Therapy
- Respiratory
- Status
- Official FDF licensing catalog (UB548)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tolazoline Mesylate Injection
Injection · 1ml:10mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB547)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Sodium Nitroprusside Injection
Injection · 2ml:50mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB546)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Bisoprolol and Amlodipine Tablets
Tablets · 5mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB545)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Bumetanide Injection
Injection · 4ml:1mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB544)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Dopamine Hydrochloride Injection
Injection · 2.5ml:50mg、5ml:100mg
- Therapy
- Others > Critical Care
- Status
- Official FDF licensing catalog (UB543)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Dobutamine Hydrochloride Injection
Injection · 5ml:100mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB542)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Metaraminol Bitartrate Injection
Injection · 1ml:10mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB541)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Noradrenaline Bitartrate Injection
Injection · 1ml:2mg、4ml:8mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB540)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Adrenaline Hydrochloride Injection
Injection · 1ml:1mg
- Therapy
- Respiratory
- Status
- Official FDF licensing catalog (UB539)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Isoprenaline Hydrochloride Injection
Injection · 1ml:0.2mg, 5ml:1mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB538)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Levosimendan Injection
Injection · 5ml:12.5mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB537)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Cilostazol Tablets
Tablets · 50mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB536)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ketorolac tromethamine Nasal Spray
— · 1.7g, 8 sprays
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB535)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States